Bridging Clinical Value &
Commercial Success
We build localised value stories aligned with clinical practice, patient and payer priorities, providing end-to-end support from early access to reimbursement, including Belgium-specific budget impact modelling and hands-on negotiation of Managed Entry Agreements.
Pricing & Reimbursement
pricing & reimbursement
Develop robust pricing models that reflect value while ensuring payer acceptance across different markets.
Market Access
Navigate complex regulatory landscapes with strategies tailored to local payer requirements.
Health Economics (HEOR)
Generate compelling evidence and value dossiers to demonstrate cost-effectiveness and Clinical value.
Policy & Advocacy
Shape the healthcare environment by engaging key stakeholders and influencing policy decisions.
Patient & Payer Engagement
Facilitate meaningful dialogue with payers and HTA bodies to align expectations and secure favourable outcomes.
Launch Excellence
Patients are at the core of everything we do. We embed access strategies throughout the entire product lifecycle to ensure seamless delivery of care.
Integrated Market Access Solutions
We bridge the gap between clinical value and commercial success through
rigorous analysis and strategic foresight.
What We Do
Fast Access from 1 January 2026
Strategic Insights
Latest thinking and analysis from our team of experts.
Our Integrated Approach
A Systematic Path to Access
A systematic approach ensuring no critical milestone is overlooked, from early-stage development to post-launch optimisation.
1
Landscape Assessment
An in-depth analysis of the current landscape, unmet needs, and payer perceptions.
2
Value Proposition
Crafting a compelling value story and gathering necessary clinical and economic evidence.
3
Strategy Development
Defining the optimal pricing, contracting, and access strategy for each target market.
4
Execution & Launch
Following up on addressing clinical and budgetary uncertainties to maintain patient access.
Executional Excellence, Patient-First
Strategic engagement and executional excellence with deep respect for the patient's voice.
why choose Axes Health
Recognised executional excellence in delivering complex market access strategies across BeNeLux markets.
Deep respect for the patient's voice integrated throughout all our strategic planning and execution.
Unmatched expertise in rare diseases with proven track records across orphan disease portfolios.
Respected partner by health authorities with established relationships across European regulatory bodies.